학술논문
289P Results of the window-of-opportunity clinical trial D-BIOMARK: Study of biomarkers of the antitumor activity of denosumab and its role as a modulator of the immune response in early breast cancer
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S300-S300
Subject
Language
ISSN
0923-7534